A novel tissue inhibitor of metalloproteinases‐1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients
Abstract Background Cachexia, a devastating syndrome in cancer patients, critically determines survival and life quality. It is characterized by impaired homeostasis of multiple organs including the liver, involves tissue wasting, and is conventionally diagnosed and classified by weight loss (WL). H...
Main Authors: | Olga Prokopchuk, Chris D. Hermann, Benjamin Schoeps, Ulrich Nitsche, Oleksii L. Prokopchuk, Percy Knolle, Helmut Friess, Marc E. Martignoni, Achim Krüger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.12680 |
Similar Items
-
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer
by: Olga Prokopchuk, et al.
Published: (2018-02-01) -
Cancer cachexia
by: Kunze Philipp, et al.
Published: (2003-11-01) -
Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study
by: Ilanna Marques Gomes daRocha, et al.
Published: (2019-04-01) -
Interleukin-8 and clinical symptoms can be prognostic indicators for advanced cancer patients with cachexia
by: Miyo Murai, et al.
Published: (2020-11-01) -
Cancer Cachexia
by: Tanadech Dechaphunkul
Published: (2011-10-01)